Researchers at Columbia University have made a significant step toward visualizing complex protein metabolism in living systems with high resolution and minimum disturbance, a longstanding goal in the scientific community. In a recent study published in ACS Chemical Biology, the team reported a light microscopy method to image where the new proteins are produced and where the old proteins are degraded inside living tissues and animals.
Proteins carry most biological functions in life. Biologists have long learnt that new proteins are produced and old ones are destroyed over time, as required by the metabolic activity of living organisms. Many complex physiological and disease processes involve protein synthesis and degradation in space and time. For example, formation of long-term memory requires activity-dependent protein synthesis in specific neurons while the devastating Huntington’s disease often disrupts protein degradation pathways of affected cells.
Technically, however, it is very challenging to visualize protein metabolism in a noninvasive and global (i.e., proteome) manner especially for live systems. Previous methods using radioactive amino acids have to work with dead samples. Imaging mass spectrometry is invasive, thereby not compatible with live systems. Fluorescence based techniques using unnatural amino acids generally require non-physiological fixation of cells.
To address this problem the team exploited a novel combination of chemical labeling and physical detection. Specifically, they coupled an emerging laser-based technique called stimulated Raman scattering (SRS) microscopy with metabolic labeling of deuterated amino acids (D-AAs) by cell’s native protein synthesis machineries.
In the specially prepared D-AAs, the normal hydrogen atoms are replaced by deuterium atoms, which exhibit almost identical physical-chemical properties to those of hydrogen except for their heavier masses. When the carbon-deuterium bond stretches, it produces a Raman scattering signal at a unique ‘frequency’ (different from natural molecules inside cells).
The newly synthesized proteins, built upon the incorporated D-AAs, can then be specifically detected by SRS through the unique vibrational signature from carbon-deuterium bonds. Using this method the team have demonstrated imaging newly synthesized protein in live cells, as reported in an earlier PNAS publication.
The team state that the current has significantly expanded the concept of coupling SRS with metabolic labeling of D-AAs. Besides monitoring protein synthesis, this technique can also probe protein degradation, by tracking the signal decay of the methyl group (CH3) attributed to pre-existing proteins. Moreover, inspired by the classic pulse-chase analysis of complex protein dynamics, two-color pulse-chase imaging was accomplished by rationally dividing the whole D-AAs collection into two structurally different sub-sets with distinct vibrational signatures. In this way the team was able to probe progression dynamics of aggregate formation of mutant huntingtin proteins in live cells.
Equipped with the much improved technique the medical community can pursue biological applications well beyond the earlier demonstration on simple cell lines. In this new study, the team imaged the spatial distribution of newly synthesized proteins inside live brain tissue slices with pronounced signal observed in dentate gyrus, suggesting high metabolic activity in this region. The intricate relationship between protein synthesis and neuronal plasticity is currently under investigation on this platform.
The team explain that the major advantage of their technique lies in its non-toxicity and minimal invasiveness, as administration of D-AAs in the model organisms appears to be non-toxic even for a long duration. The team has mapped newly synthesized protein in living animals including zebrafish and mice. Strong signals are detected in the somites at the embryonic zebrafish tail and the liver and intestine tissues from examined mice. All these new demonstrations support the technique for in vivo interrogation.
The team summise that in addition to basic research the technique could also contribute greatly to translational applications. Considering that stable isotope labeling and SRS imaging are both compatible with live humans, the researchers envision a bright prospect of applying this platform to performing diagnostic and therapeutic imaging in humans.
Source: Columbia University
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.